# RIG 101 Trial in Healthy Adults and Adults With Asthma

> **NCT07488897** · PHASE1,PHASE2 · RECRUITING · sponsor: **RIGImmune Inc.** · enrollment: 82 (estimated)

## Conditions studied

- Healthy Adult Participants
- Asthma Exacerbation
- Safety and Efficacy

## Interventions

- **DRUG:** RIG-101
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07488897
- **Lead sponsor:** RIGImmune Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07488897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07488897, "RIG 101 Trial in Healthy Adults and Adults With Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07488897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*